Experience
- HAYA TherapeuticsBoard Observercurrent2025 — present
- +ND CapitalPrincipalcurrent2025 — present
- +ND CapitalSenior Associate2023 — 2025
- +ND CapitalAssociate2021 — 2022
- +ND CapitalInnovation Fellow2021
- Constructive BioBoard Observercurrent2025 — present
- Timeline®Board Observercurrent2024 — present
- Notify TherapeuticsBoard Observercurrent2023 — present
- AIRNABoard Observercurrent2022 — present
- Vandria SABoard Observercurrent2021 — present
- EVIR TherapeuticsBoard Observercurrent2021 — present
- Osasuna TherapeuticsBoard Observer2022 — 2025
- CellPointBoard Observer2021 — 2022
- SOPHiA GENETICSGenomics Research Expert2020 — 2021
- SOPHiA GENETICSSenior NGS Scientist2019 — 2020
- SOPHiA GENETICSNGS Scientist2016 — 2019
- EPFL (École polytechnique fédérale de Lausanne)Research Assistant2011 — 2016
- The University of TokyoSummer Intern2015
- Universidade Federal de Santa CatarinaUndergraduate Researcher2006 — 2011Center of Structural and Molecular Biology
Education
- EPFLCAS in Management of Biotech, Medtech & Pharma Ventures2016
- EPFLDoctor of Philosophy (PhD), PhD in Biotechnology and Bioengineering2011 — 2016
- Universidade Federal de Santa CatarinaBachelor of Science (BSc), Biology/Biological Sciences2006 — 2011
Skills & more
Senior Stakeholder ManagementPortfolio ManagementBusiness DevelopmentResearch SkillsHistochemistryNext-Generation Sequencing (NGS)Molecular DiagnosticsProject Management1Business StrategyBioinformaticsVenture CapitalStem Cells5
+11 more
GeneticsGenomicsMolecular BiologyEpigeneticsHigh Throughput ScreeningBiochemistryMolecular CloningPCRStrategic PlanningResearch TranslationSourcing and Due DiligenceLanguages English · French · German · Italian · Portuguese · Spanish
- PRINCE2® Foundation Certification Training — AXELOS Global Best Practice
From Gabriela's professional profile.
Colleagues at +ND Capital
Aditya Rajagopal
Venture Partner at +ND Capital
Alison Palmer
Vice President of the General Partner at +ND Capital
André Châtelain
Advisor at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Carl Pabo
Advisor at +ND Capital
Cathleen O’Connor
Executive Assistant at +ND Capital
Eric Moessinger
Partner at +ND Capital
Jonathan Nicholson
Executive Director of the General Partner at +ND Capital
Network4
Alison Palmer
Vice President of the General Partner at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Kirill Kuzmichev
Principal at +ND Capital
Klaus Dugi
Chief Medical Advisor & Venture Partner at +ND Capital
Investors connected to Gabriela in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Gabriela Ecco work?
- Gabriela Ecco is Principal at +ND Capital.
- What check size does Gabriela Ecco write?
- Gabriela Ecco typically writes checks of $100K – $5M.
Same school
Also attended EPFL99
Bouraux LeopoldAI & Data Engineer at Newfund CapitalJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgArzu TekirGeneral Partner at Treeo VCLaure BouchezExecutives in Residence at GENERAL INCEPTIONElena BattistelloAnalyst at Novartis Venture Fund
+ 93 more
Also attended Universidade Federal de Santa Catarina16
Luiz Antonio MacariniAI & Machine Learning Engineer at Struck CapitalErwin DassenVenture Partner at FrachtisKatharina FriePartner at eCAPITAL ENTREPRENEURIAL PARTNERSFranco ZanettePartner at ABSeed VenturesPedro CoutinhoPartner, Buyouts at Explorer InvestmentsFrederico S. B. MesquitaDr. at Lotus Investment Strategies
+ 10 more
